MINIMALLY INVASIVE IMPLANT MANDIBULAR OVERDENTURE FOR TYPE-1 DIABETIC PATIENTS
Eldidi, L., Abdelhamid, A., Hommos, A., Eldakkak, S., El Zawawy, H. (2019). MINIMALLY INVASIVE IMPLANT MANDIBULAR OVERDENTURE FOR TYPE-1 DIABETIC PATIENTS. EKB Journal Management System, 44(1), 81-86. doi: 10.21608/adjalexu.2019.57583
Lubna M. Eldidi; Ahmad M. Abdelhamid; Ahmed M. Hommos; Sherif M. Eldakkak; Hanaa T. El Zawawy. "MINIMALLY INVASIVE IMPLANT MANDIBULAR OVERDENTURE FOR TYPE-1 DIABETIC PATIENTS". EKB Journal Management System, 44, 1, 2019, 81-86. doi: 10.21608/adjalexu.2019.57583
Eldidi, L., Abdelhamid, A., Hommos, A., Eldakkak, S., El Zawawy, H. (2019). 'MINIMALLY INVASIVE IMPLANT MANDIBULAR OVERDENTURE FOR TYPE-1 DIABETIC PATIENTS', EKB Journal Management System, 44(1), pp. 81-86. doi: 10.21608/adjalexu.2019.57583
Eldidi, L., Abdelhamid, A., Hommos, A., Eldakkak, S., El Zawawy, H. MINIMALLY INVASIVE IMPLANT MANDIBULAR OVERDENTURE FOR TYPE-1 DIABETIC PATIENTS. EKB Journal Management System, 2019; 44(1): 81-86. doi: 10.21608/adjalexu.2019.57583

MINIMALLY INVASIVE IMPLANT MANDIBULAR OVERDENTURE FOR TYPE-1 DIABETIC PATIENTS

Alexandria Dental Journal
Article 14, Volume 44, Issue 1, April 2019, Page 81-86  XML PDF (653.95 K)
Document Type: Original Article
DOI: 10.21608/adjalexu.2019.57583
View on SCiNiTO View on SCiNiTO
Authors
Lubna M. Eldidi* 1; Ahmad M. Abdelhamid2; Ahmed M. Hommos3; Sherif M. Eldakkak4; Hanaa T. El Zawawy5
1Assistant Lecturer of Removable Prosthodontics, Faculty of Dentistry, Alexandria University, Egypt
2Professor of Removable Prosthodontics, Faculty of Dentistry, Alexandria University, Egypt.
3Professor of Oral Medicine, Periodontology, Oral Diagnosis and Radiology, Faculty of Dentistry, Alexandria University, Egypt.
4Lecturer of Removable Prosthodontics, Faculty of Dentistry, Alexandria University, Egypt
5Lecturer of Internal Medicine and Endocrinology, Faculty of Medicine, Alexandria University, Egypt.
Abstract
INTRODUCTION: Diabetes Mellitus (DM) is a systemic disease that affects large part of the population and is considered a relative contraindication to implant therapy. However, there are studies showing that the survival rate of implants in type-2 diabetic patients is approximately 90%, approaching that of non-diabetic patients. It is also shown that these results are strictly correlated with the importance of glycemic control to provide predictability of success rates and improve osseointegration of the implants inserted. There is no evidence whether controlled type-1 diabetes is or is not a risk factor for implant failure. OBJECTIVES: The objective of this study was to clinically and radiographically evaluate the success of implant overdenture in controlled type-1 diabetic patients. MATERIALS AND METHODS: Ten completely edentulous well controlled type-1 and ten non-diabetic patients were selected and divided into group I and II respectively. All patients received three implant assisted mandibular overdentures through minimally invasive flapless technique. Clinical evaluation of implant stability was performed using Osstell ISQ immediately after implant placement (base line), four months and one year after prosthesis insertion. Level of alveolar bone loss around each abutment was also evaluated using Cone Beam Computed Tomography (CBCT) at the time of final prosthesis insertion (base line), four months and one year after insertion. RESULTS: Of the ten patients in the study group, two patients were lost yielding a success rate of 80 % in group I. Clinical results of implant stability test showed significant decrease in stability in the study group as compared to the control group, also radiographical results revealed significant increase in amount of average crestal bone loss in the diabetic patients. CONCLUSIONS: Within the limitations of this study, and based on the clinical level, the implant overdenture may be recognized as being predictable treatment option for controlled type-1 diabetic patients.
Keywords
diabetes; type 1; Implant overdenture; Minimally invasive
References
  1. Zarb G A. The edentulous milieu. J Prosthet Dent 1983; 49: 825-831.
  2. Bornstein MM, Cionca N, Mombelli A. Systemic Conditions and Treatments as Risks for Implant Therapy. Int J Oral Maxillofac Implants 2009; 24:12–27.
  3. Blanchaert RH. Implants in the medically challenged patient. Dent Clin North Am 1998; 42:35–45.
  4. Balshi TJ, Wolfinger GJ. Dental implants in the diabetic patient: a retrospective study. Implant Dent 1999; 8:355-9.
  5. Shernoff AF, Colwell JA, Bingham SF. Implants for type II diabetic patients: interim report. VA Implants in Diabetes Study Group. Implant Dent 1994; 3:183-5.
  6. Smith RA, Berger R, Dodson TB. Risk Factors associated with dental implants in healthy and medically compromised patients. Int J Oral Maxillofac Implants 1992; 7:367-72.
  7. Goodson WH, Hunt TK. Wound healing and the diabetic Patient. Surg Gynecol Obstet 1979; 149:600-8.
  8. Larkin JG, Frier BM, Ireland JT. Diabetis Mellitus and infection. Postgrad Med J 1985; 61:233-7.
  9. Rothwell BR, Richard EL. Diabetes mellitus: Medical and Dental Considerations. Spec Care Dentist 1984; 4:58-65.
  10. American academy of periodontology. Diabetes and periodontal disease (position paper). J Periodontol 1999; 70:935–49.
  11. Cianciola RJ, Park BH, Bruck E, Mosovich L, Genco RJ. Prevalence of periodontal disease in insulin dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc 1982; 104:653–60.
  12. Schlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990; 121:532–6.
  13. Grossi S, Skrepcinski F, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol 1996; 67:1094-102.
  14. Arbildo H, Lamas C, Camara D, Vásquez H. Dental implant survival rate in well-controlled diabetic patients. A systematic review. J Oral Res 2015; 4: 404-10.
  15. Dominic H. Evidence unclear on whether Type I or II diabetes increases the risk of implant failure. EvidenceBased Dentistry 2014; 15:102-3.
  16. Moraschini V, Barboza ESP. The impact of diabetes on dental implant failure: a systematic review and metaanalysis. Int J Oral Maxillofac Surg 2016; 45:1237– 45.
  17. Alsaadi G, Quirynen M, Koma´rek A, van Steenberghe D. Impact of local and systemic factors on the incidence of late oral implant loss. Clin Oral Implants Res 2008; 19:670–6.
  18. Oates TW, Huynh-Ba G, Vargas A, Alexander P, Feine J. A critical review of diabetes, glycemic control, and dental implant therapy. Clin Oral Implants Res 2013; 24:117–27.
  19. Chanavaz M. Patient screening and medical evaluation for implant and preprosthetic surgery. J Oral Implantol 1998; 24:222–9.
  20. Adell R. The surgical principles of osseointegration. In: Worthington P, Brånemark PI. Advanced Osseointegration Surgery. Chicago: Quintessence, 1992:94–107.
  21. Valero AM, García FJ, Ballester HA, Rueda LC. Effects of diabetes on the osseointegration of dental implants. Med Oral Patol Oral Cir Bucal 2007; 12:38-43.
  22. Chrcanovic BR, Albrektsson T, Wenneberg A. Diabetes and Oral Implant Failure A Systematic Review. J Dent Res 2014; 93:859–67.
  23. Klokkevold PR, Han TJ. How do smoking, diabetes, and periodontitis affect outcomes of implant treatment? Int J Oral Maxillofac Implants 2007; 22:173-202.
  24. Cosyn J, Vandenbulcke E, Browaeys H, Van Maele G, De Bruyn H. Factors associated with failure of surfacemodified implants up to four years of function. Clin Implant Dent Relat Res 2012; 14:347–58.
  25. Rocchietta I, Nisand D. A review assessing the quality of reporting of risk factor research in implant dentistry using smoking, diabetes and periodontitis and implant loss as an outcome: critical aspects in design and outcome assessment. J Clin Periodontol 2012; 39:114–21.
  26. Ramasamy R, Schmidt AM. Etiology of diabetes mellitus In: Lamster IB, Diabetes Mellitus and Oral Health: An Interprofessional Approach. John Wiley & Sons, Inc.; 2014:3-26.
  27. Marchand F, Raskin A, Dionnes-Hornes A, Barry T, Dubois N, Valero B et al. Dental implants and diabetes: conditions for success. Diabetes Metab 2012; 38:14–9.
  28. Locatto ME, Abranzon H, Caferra D, Fernández MC, Alloatti R, Puche RC. Growth and development of bone mass in untreated alloxan diabetic rats. Effects of collagen glycosilation and parathyroid activity on bone turnover. Bone Miner. 1993; 23:129–44.
  29. Gutiérrez JL, Bagán JV, Bascones A, Llamas R, Llena J, Morales A, et al. Consensus document on the use of antibiotic prophylaxis in dental surgery and procedures. Med Oral Patol Oral Cir Bucal 2006; 11:188-205.
  30. Morris HF, Ochi S, Winkler S. Implant survival in patients with type 2 diabetes: placement to 36 months. Ann Periodontal 2000; 5:157-65.
  31. Esposito M, Grusovin MG, Chew YS, Coulthard P, Worthington HV. One-stage versus two-stage implant placement. A Cochrane Systematic Review of Randomised Controlled Clinical Trials. Eur J Oral Implantol 2009; 2:91- 9.
  32. Romero-Ruiz MM, Mosquera-Perez R, Gutierrez-Perez JL, Torres-Lagares D. Flapless implant surgery: A review of the literature and 3 case reports. J Clin Exp Dent. 2015; 7:146- 52.
  33. Meloni SM, De Riu G, Pisano M, Tullio A, Lolli FM, Deledda A, Campus G. Clinical Study: Implant Restoration of Edentulous Jaws with 3D Software Planning, Guided Surgery, Immediate Loading, and CAD-CAM Full Arch Frameworks. Int J Dent 2013:1-7.
  34. Mericske-stern RD, Taylor TD, Belser U. Management of the edentulous patient. Clin Oral Impl Res 2000; 11:108– 25.
  35. Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: a review and proposed criteria of success. Int J Oral Maxillofac Implants 1986; 1:11–25.
  36. Mathiassen B, Nielsen S, Ditzel J, Rodbro P. Long-term bone loss in insulin-dependent diabetes mellitus. J Intern Med 1990; 227:325–7.
  37. Kokovic V, Vasovic M, Shafi E. Assessment of primary implant stability of self-tapping implants using the resonance frequency analysis. The Saudi Journal for Dental Research 2014; 5:35-9.
  38. Friberg B, Sennerby L, Meredith N, Lekholm U. A comparison between cutting torque and resonance frequency measurements of maxillary implants. A 20- month clinical study. Int J Oral Maxillofac Surg 1999; 28:297–303.
  39. Heo SJ, Sennerby L, Odersjö M, Gränström G, Tjellström A, Meredith N. Stability measurements of craniofacial implants by means of resonance frequency analysis. A clinical pilot study. J Laryngol Otol 1998; 112:537–42.
  40. Meredith N, Book K, Friberg B, Jemt T, Sennerby L. Resonance frequency measurements of implant stability in vivo. A cross-sectional and longitudinal study of resonance frequency measurements on implants in the edentulous and partially dentate maxilla. Clin Oral Implants Res 1997; 8:226–33.
Statistics
Article View: 275
PDF Download: 558